Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy

BACKGROUND: Clinical studies have suggested that prostate health index (phi) outperforms prostate-specific antigen (PSA) tests in prostate cancer detection. The cost-effectiveness of phi with different cutoffs is poorly understood in the context of decision making for prostate biopsy. METHODS: In a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Da, Yang, Xiaoqun, Wu, Yishuo, Lin, Xiaoling, Xu, Danfeng, Na, Rong, Xu, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732507/
https://www.ncbi.nlm.nih.gov/pubmed/33330035
http://dx.doi.org/10.3389/fonc.2020.565382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732507/
https://www.ncbi.nlm.nih.gov/pubmed/33330035
http://dx.doi.org/10.3389/fonc.2020.565382

Ejemplares similares